Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1176P is a *human pseudogene* associated with the U6 small nuclear RNA (snRNA) gene family[6][5]. U6 snRNA itself is a highly conserved non-coding RNA central to the splicing of pre-mRNA as part of the spliceosome complex[1][3]. The U6 snRNA gene is present in multiple copies in vertebrate genomes; many of these are pseudogenes, like RNU6-1176P, which do not produce functional RNA or protein and typically have no role in cellular processes[3][7]. While a small number of pseudogenes can contribute to disease through regulatory or recombination mechanisms[2][4], there is no evidence that RNU6-1176P plays any such role. It is not considered a drug target, has no documented disease involvement, and lacks known drug or biomarker relevance[5].
Not applicable (see above)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1176, pseudogene (RNU6-1176P).